Published • loading... • Updated
Leica Biosystems to Acquire StatLab
- Leica Biosystems, a Danaher company, plans to acquire StatLab Medical Products from Linden Capital Partners and Audax Private Equity.
- After the acquisition closes, StatLab will become part of Leica Biosystems.
- StatLab has supplied high-quality products for anatomic pathology laboratories for over 50 years across pre-analytical and analytical histology workflows.
- The deal is expected to close by the end of 2026, pending regulatory approvals, with undisclosed financial terms.
Insights by Ground AI
21 Articles
21 Articles
abc12/WJRT+16 Reposted by 16 other sources
Leica Biosystems to Acquire StatLab
DEER PARK, Ill., July 14, 2026 /PRNewswire/ -- Leica Biosystems, an operating company of Danaher (the "Company"), and a global leader in anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has entered into a definitive agreement…
·Flint, United States
Read Full Article
analytica-world.comReposted by 
bionity.com
bionity.comLeica Biosystems, a subsidiary of Danaher (the company), and a leading global provider of solutions for anatomical pathology to promote accurate cancer diagnostics, announced that the Company has entered into a final agreement to acquire the privately owned subsidiary of Leica Biosystems.
Coverage Details
Total News Sources21
Leaning Left3Leaning Right2Center11Last UpdatedBias Distribution69% Center
Bias Distribution
- 69% of the sources are Center
69% Center
L 19%
C 69%
12%
Factuality
To view factuality data please Upgrade to Premium
